Thomann competitive analysis

Explore patent oppositions filed by Thomann against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 10, 2026
Patent NumberTitleApplicantOpposition Date
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS SASep 28, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS SASep 21, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS SASep 6, 2023
Virion-Like Delivery Particles For Self-Replicating Rna MoleculesGLAXOSMITHKLINE BIOLOGICALS SAJul 11, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS SAFeb 21, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS SAFeb 21, 2023
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINE BIOLOGICALS SADec 9, 2022
Immunoactivating Antigen-Binding MoleculeCHUGAI SEIYAKU KABUSHIKI KAISHAJul 13, 2022

Latest PTAB cases involving Thomann

Discover the latest PTAB cases involving Thomann, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Thomann with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
THOMANN8 - - -
CHUGAI SEIYAKU KABUSHIKI KAISHA3114 - 1
GLAXOSMITHKLINE BIOLOGICALS SA2610029
NOVARTIS12542 - 21